 | Up a level |
Pollard, Richard B., Rockstroh, Jurgen K., Pantaleo, Giuseppe, Asmuth, David M., Peters, Barry, Lazzarin, Adriano, Garcia, Felipe, Ellefsen, Kim, Podzamczer, Daniel, van Lunzen, Jan, Arasteh, Keikawus, Schuermann, Dirk, Clotet, Bonaventura, Hardy, W. David, Mitsuyasu, Ronald, Moyle, Graeme, Plettenberg, Andreas, Fisher, Martin, Fatkenheuer, Gerd, Fischl, Margaret, Taiwo, Babafemi, Baksaas, Ingebjorg, Jolliffe, Darren, Persson, Stefan, Jelmert, Oyvind, Hovden, Arnt-Ove, Sommerfelt, Maja A., Wendel-Hansen, Vidar and Sorensen, Birger (2014). Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis., 14 (4). S. 291 - 301. OXFORD: ELSEVIER SCI LTD. ISSN 1474-4457
Vieillard, Vincent, Combadiere, Behazine, Tubiana, Roland, Launay, Odile, Pialoux, Gilles, Cotte, Laurent, Girard, Pierre-Marie, Simon, Anne, Dudoit, Yasmine, Reynes, Jacques, Rockstroh, Juergen, Garcia, Felipe, Gatell, Jose, Devidas, Alain, Yazdanpanah, Yazdan, Weiss, Laurence, Faetkenheuer, Gerd, Autran, Brigitte, Joyeux, Delphine, Gharakhanian, Shahin, Debre, Patrice and Katlama, Christine (2019). HIV therapeutic vaccine enhances non-exhausted CD4(+) T cells in a randomised phase 2 trial. npj Vaccines, 4. LONDON: SPRINGERNATURE. ISSN 2059-0105